Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 44528 | 14.72 |
09:34 ET | 6643 | 14.68 |
09:36 ET | 2724 | 14.72 |
09:38 ET | 3200 | 14.75 |
09:39 ET | 882 | 14.76 |
09:41 ET | 299 | 14.74 |
09:43 ET | 100 | 14.75 |
09:45 ET | 500 | 14.7475 |
09:48 ET | 22890 | 14.76 |
09:50 ET | 6449 | 14.76 |
09:52 ET | 9801 | 14.77 |
09:54 ET | 2045 | 14.75 |
09:56 ET | 5400 | 14.735 |
09:57 ET | 3236 | 14.75 |
09:59 ET | 8479 | 14.75 |
10:01 ET | 2714 | 14.75 |
10:03 ET | 6334 | 14.73 |
10:06 ET | 2688 | 14.73 |
10:08 ET | 993 | 14.715 |
10:10 ET | 1864 | 14.68 |
10:12 ET | 4238 | 14.71 |
10:14 ET | 600 | 14.7 |
10:15 ET | 4760 | 14.7 |
10:17 ET | 3900 | 14.7 |
10:19 ET | 2810 | 14.716 |
10:21 ET | 3381 | 14.7 |
10:24 ET | 11561 | 14.7 |
10:26 ET | 6642 | 14.71 |
10:28 ET | 4466 | 14.71 |
10:30 ET | 8200 | 14.7 |
10:32 ET | 3103 | 14.7 |
10:33 ET | 1664 | 14.695 |
10:35 ET | 2623 | 14.69 |
10:37 ET | 2043 | 14.7 |
10:39 ET | 3439 | 14.7 |
10:42 ET | 900 | 14.7 |
10:44 ET | 500 | 14.7 |
10:46 ET | 2304 | 14.7 |
10:48 ET | 300 | 14.7 |
10:50 ET | 2130 | 14.695 |
10:51 ET | 1283 | 14.695 |
10:53 ET | 4986 | 14.71 |
10:55 ET | 2100 | 14.7 |
10:57 ET | 2415 | 14.695 |
11:00 ET | 1300 | 14.685 |
11:02 ET | 5549 | 14.68 |
11:04 ET | 1725 | 14.68 |
11:06 ET | 1906 | 14.655 |
11:08 ET | 2618 | 14.6593 |
11:09 ET | 4303 | 14.665 |
11:11 ET | 700 | 14.66 |
11:13 ET | 1200 | 14.665 |
11:15 ET | 3100 | 14.7 |
11:18 ET | 900 | 14.7 |
11:20 ET | 4673 | 14.7 |
11:22 ET | 2106 | 14.71 |
11:24 ET | 5225 | 14.72 |
11:26 ET | 1913 | 14.72 |
11:27 ET | 2100 | 14.7175 |
11:29 ET | 3895 | 14.715 |
11:31 ET | 21050 | 14.72 |
11:33 ET | 10239 | 14.745 |
11:36 ET | 3641 | 14.8 |
11:38 ET | 20159 | 14.79 |
11:40 ET | 1600 | 14.8 |
11:42 ET | 2828 | 14.79 |
11:44 ET | 2400 | 14.785 |
11:45 ET | 7895 | 14.8 |
11:47 ET | 2700 | 14.8 |
11:49 ET | 1700 | 14.8 |
11:51 ET | 1200 | 14.8 |
11:54 ET | 3579 | 14.795 |
11:56 ET | 1950 | 14.8 |
11:58 ET | 3100 | 14.825 |
12:00 ET | 1300 | 14.81 |
12:02 ET | 3256 | 14.805 |
12:03 ET | 1000 | 14.8 |
12:05 ET | 1930 | 14.805 |
12:07 ET | 3953 | 14.8 |
12:09 ET | 1810 | 14.795 |
12:12 ET | 3992 | 14.81 |
12:14 ET | 1561 | 14.81 |
12:16 ET | 1236 | 14.81 |
12:18 ET | 6295 | 14.82 |
12:20 ET | 2321 | 14.83 |
12:21 ET | 1400 | 14.83 |
12:23 ET | 3050 | 14.815 |
12:25 ET | 200 | 14.815 |
12:27 ET | 1500 | 14.81 |
12:30 ET | 996 | 14.79 |
12:32 ET | 1200 | 14.79 |
12:34 ET | 500 | 14.77 |
12:36 ET | 967 | 14.78 |
12:38 ET | 4200 | 14.78 |
12:39 ET | 2252 | 14.77 |
12:41 ET | 1076 | 14.76 |
12:43 ET | 1748 | 14.76 |
12:45 ET | 2238 | 14.76 |
12:48 ET | 4194 | 14.77 |
12:50 ET | 1310 | 14.78 |
12:52 ET | 3837 | 14.81 |
12:54 ET | 8907 | 14.86 |
12:56 ET | 1069 | 14.86 |
12:57 ET | 4714 | 14.85 |
12:59 ET | 20147 | 14.85 |
01:01 ET | 2170 | 14.85 |
01:03 ET | 1300 | 14.845 |
01:06 ET | 719 | 14.845 |
01:08 ET | 600 | 14.85 |
01:10 ET | 1428 | 14.845 |
01:12 ET | 2851 | 14.835 |
01:14 ET | 1417 | 14.82 |
01:15 ET | 913 | 14.8145 |
01:17 ET | 400 | 14.805 |
01:19 ET | 3132 | 14.81 |
01:21 ET | 8399 | 14.825 |
01:24 ET | 5356 | 14.85 |
01:26 ET | 1767 | 14.85 |
01:28 ET | 100 | 14.855 |
01:30 ET | 2424 | 14.85 |
01:32 ET | 700 | 14.85 |
01:33 ET | 2200 | 14.8558 |
01:35 ET | 1800 | 14.85 |
01:37 ET | 5900 | 14.85 |
01:39 ET | 9433 | 14.85 |
01:42 ET | 3436 | 14.79 |
01:44 ET | 400 | 14.78 |
01:46 ET | 491 | 14.79 |
01:48 ET | 1808 | 14.8 |
01:50 ET | 5959 | 14.82 |
01:51 ET | 1400 | 14.805 |
01:53 ET | 2974 | 14.81 |
01:55 ET | 900 | 14.815 |
01:57 ET | 1600 | 14.82 |
02:00 ET | 6997 | 14.84 |
02:02 ET | 2223 | 14.835 |
02:04 ET | 3334 | 14.84 |
02:06 ET | 5704 | 14.845 |
02:08 ET | 12695 | 14.795 |
02:09 ET | 2715 | 14.77 |
02:11 ET | 2453 | 14.76 |
02:13 ET | 1950 | 14.735 |
02:15 ET | 1961 | 14.7202 |
02:18 ET | 1250 | 14.72 |
02:20 ET | 2522 | 14.745 |
02:22 ET | 1628 | 14.73 |
02:24 ET | 3197 | 14.74 |
02:26 ET | 958 | 14.735 |
02:27 ET | 600 | 14.735 |
02:29 ET | 800 | 14.73 |
02:31 ET | 2549 | 14.745 |
02:33 ET | 800 | 14.73 |
02:36 ET | 1215 | 14.73 |
02:38 ET | 3076 | 14.75 |
02:40 ET | 500 | 14.75 |
02:42 ET | 13739 | 14.77 |
02:44 ET | 500 | 14.77 |
02:45 ET | 2278 | 14.78 |
02:47 ET | 300 | 14.785 |
02:49 ET | 785 | 14.78 |
02:51 ET | 4473 | 14.775 |
02:54 ET | 2153 | 14.785 |
02:56 ET | 5128 | 14.805 |
02:58 ET | 614 | 14.8 |
03:00 ET | 300 | 14.79 |
03:02 ET | 4025 | 14.79 |
03:03 ET | 2904 | 14.785 |
03:05 ET | 14774 | 14.79 |
03:07 ET | 800 | 14.785 |
03:09 ET | 5890 | 14.8 |
03:12 ET | 2986 | 14.81 |
03:14 ET | 460 | 14.8 |
03:16 ET | 2701 | 14.81 |
03:18 ET | 400 | 14.8 |
03:20 ET | 500 | 14.79 |
03:21 ET | 3283 | 14.805 |
03:23 ET | 1000 | 14.805 |
03:25 ET | 8761 | 14.82 |
03:27 ET | 5363 | 14.845 |
03:30 ET | 6476 | 14.865 |
03:32 ET | 4210 | 14.875 |
03:34 ET | 3843 | 14.87 |
03:36 ET | 4900 | 14.865 |
03:38 ET | 8186 | 14.865 |
03:39 ET | 8929 | 14.87 |
03:41 ET | 18087 | 14.855 |
03:43 ET | 400 | 14.86 |
03:45 ET | 4523 | 14.85 |
03:48 ET | 5331 | 14.855 |
03:50 ET | 6637 | 14.855 |
03:52 ET | 10706 | 14.89 |
03:54 ET | 16780 | 14.875 |
03:56 ET | 42125 | 14.83 |
03:57 ET | 62268 | 14.795 |
03:59 ET | 109196 | 14.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.5B | -1,149.2x | --- |
Azenta Inc | 2.8B | -18.6x | --- |
PTC Therapeutics Inc | 2.6B | -4.3x | --- |
Guardant Health Inc | 3.2B | -6.5x | --- |
Novavax Inc | 2.0B | -4.1x | --- |
Amicus Therapeutics Inc | 2.8B | -19.4x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,149.2x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 274.3x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.